The physical space of the MSK Library is scheduled to close to visitors on Friday, May 17, 2024. Please visit this guide for more information.
Why Comorbidities are Important:
Normal Age-Related Changes:
Comorbidity is recognized as having an unfavorable effect on life expectancy of patients with cancer, as well as influencing clinical decision making; older adults are at increased risk of adverse health outcomes if they have any of the following:
Behavioral Risk Factors
Medication-Related Risk Factors
Chemotherapy-Related Risk Factors: (Lichtman et al. 2007 and Hurria et al., 2011)
(see chemotherapy index)
Radiation-Related Risk Factors
Assessment:
1. Screening Questions
2. Observations
3. Screening Tests and Measurements
4. Physical Assessment:
Nursing Intervention:
Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Borden, W.B., Bravata, D.M., Dai, S., Ford, E.S., Fox, C.S., Franco, S., Fullerton, H.J., Gillespie, C., Hailpern, S.M., Heit, J.A., Howard, V.J., Huffman, M.D., Kissela, B.M., Kittner, S.J., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Magid, D., Marcus, G.M., Marelli, A., Matchar, D.B., McGuire, D.K.,Mohler, E.R., Moy, C.S., Mussolino, M.E., Nichol, G., Paynter, N.P., Schreiner, P.J., Sorlie, P.D., Stein, J., Turan, T.N., Virani, S.S., Wong, N.D., Woo, D., Turner, M.B.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2013). Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation, 127(1): e6-e245.
Barnett, K. Mercer, S.W. Norbury, M. Watt, G. Wyke, S., & Guthrie, B. (2012). Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet 380(9836): 37-43.
Charlson, M., Szatrowski, T.P., Peterson, J., Gold, J. (1994). Validation of a combined comorbidity index. J Clin Epidemiol, 47(11): 1245-51.
Della Porta, M.G. & Malcovati, L. (2009). Clinical relevance of extra-hemotologic comorbidity in the management of patients with myelodysplastic syndrome. Haematologica, 94(5): 602-606.
Edwards, B.K., Noone, A.M., Mariotto, A.B., Simard, E.P., Boscoe, F.P., Henley, S.J., Jemal, A., Cho, H., Anderson, R.N., Kohler, B.A., Eheman, C.R., Ward, E.M. (2014). Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 120(9): 1290-314.
Farage, M.A., Miller, K.W., Berardesca, E., Maibach, H.I. (2009). Clinical implications of aging skin: cutaneous disorders in the elderly. American Journal of Clinical Dermatology, 10(2): 73-86.
Fejer, R. & Ruhe, A. (2012). What is the prevalence of musculoskeletal problems in the elderly population in developed countries? A systematic critical literature review. Chiropractic & Manual Therapies, 20(1): 31.
Grassi, M., Petraccia, L., Munnini, G., Fontana, M., Scarno, A., Sabetta, S., Fraioli, A. (2011). Changes, functional disorders, and diseases in the gastrointestinal tract of elderly. Nutr Hosp, 26(4): 659-668.
Hurria, A., Togawa, K., Mohile, S.G., Owusu, C., Klepin, H.D., Gross, C.P., Lichtman, S.M., Gajra, A., Bhatia, S., Katheria, V., Klapper, S., Hansen, K., Ramani, R., Lachs, M., Wong, F.L., Tew, W.P. (2011). Predicting chemotherapy toxicity in older adults with cancer: A prospective multicenter study. Journal of Clinical Oncology, 29(25): 3457-3465.
Jorgensen, T.L., Hallas, J., Friis, S., & Herrstedt, J. (2012). Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. British Journal of Cancer, 106(7), 1353-1360.
Kalyani, R.R., Corriere, M., & Ferrucci, L. (2014). Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. The Lancet Diabetes & Endocrinology, 2(10), 819-829.
Lichtman, S.M., Wildiers, H., Chatelut, E., Steer, C., Budman, D., Morrison, V.A., Tranchard, B., Shapira, I., Aapro, M.; International Society of Geriatric Oncology Chemotherapy Taskforce. (2007). International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in in older patients--an analysis of the medical literature. Journal of Clinical Oncology, 25(14): 1832-1843.
Pappa, T. & Alevizaki, M. (2012). Mechanisms in endocrinology: endogenous sex steroids and cardio- and cerebro-vascular disease in the postmenopausal period. European Journal of Endocrinology, 167(2): 145-156.
Roberts, D.S., Lin, H.W., & Bhattacharyya, N. (2013). Health care practice patterns for balance disorders in the elderly. Laryngoscope, 123(10): 2539-2543.
Rodin, J. (2014). Health, control, and aging. In M.M. Baltes & P.B. Baltes (Eds.), The psychology of control and aging (139-165). Psychology Press.
Salive, M.E. (2013). Multimorbidity in older adults. Epidemiologic reviews, 35: 75-83.
Savva, G.M., Wharton, S.B., Ince, P.G., Forster, G., Matthews, F.E., & Brayne, C. (2009). Age, neuropathology, and dementia. New England Journal of Medicine, 360(22): 2303-2309.
Siegel, R., Naishadham, D., & Jemal, A. (2013). Cancer Statistics, 2013. CA: A Cancer Journal for Clinicians, 63(1): 11-30.
Smith, C.M. & Cotter, V.T. (2012). Age related changes in health. In M. Boltz, E. Capezuti, T. Fulmer, & D. Zwicker (Eds.) Evidence-based geriatric nursing protocols for best practice (4th ed.). New York: Springer Publishing.
Van Remoortel, H., Hornikx, M., Langer, D., Burtin, C., Everaerts, S., Verhamme, P., Boonen, S., Goselink, R., Decramer, M., Troosters, T., & Janssens, W. (2014). Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease. American Journal of Respiratory Critical Care Medicine, 189(1): 30-38.
Whitson, H.E., Boyd., C.M. (2015). Managing multiple comorbidities. In K.E. Schumader & H.N. Sokol (Eds.), Uptodate. Retrieved from http://www.uptodate.com/contents/managing-multiple-comorbidities.